Related Experiment Videos
Human haptocorrin in hepatocellular carcinoma
F Boisson1, S Fremont, C Migeon
1INSERM U308, Medical and Pediatric Biochemistry Lab, Faculty of Medicine, Vandoeuvre, France.
Cancer Detection and Prevention
|April 2, 1999
Summary
Haptocorrin (HC), a vitamin B12 binder, is not typically stored in healthy liver cells but is present in hepatocellular carcinoma (HCC) cells and surrounding tissues. This suggests altered HC synthesis and uptake in liver cancer.
Area of Science:
- Hepatology
- Oncology
- Biochemistry
Background:
- Haptocorrin (HC) is a vitamin B12 binding protein.
- Elevated serum HC levels are observed in hepatocellular carcinoma (HCC).
- The hepatic storage and expression of HC in liver cancer remain unclear.
Purpose of the Study:
- To investigate the presence and localization of haptocorrin (HC) within hepatic cells.
- To determine if HC storage is altered during hepatic carcinogenesis, specifically in HCC.
- To elucidate the mechanisms behind elevated serum HC levels in HCC patients.
Main Methods:
- Immunohistochemistry was employed to analyze HC expression.
- Liver tissue samples from normal/steatosis (N=22), cirrhosis (N=13), and HCC (N=31) were examined.
- Staining intensity and localization of HC in cancerous and non-cancerous hepatocytes were assessed.
Main Results:
- Haptocorrin (HC) was largely absent in normal and steatotic liver tissues, with minimal detection in one cirrhotic case.
- Weak to moderate cytoplasmic staining for HC was observed in 93% of HCC cells.
- Non-cancerous hepatocytes surrounding tumors (95%) and pseudoglandular secretions also showed significant HC staining.
Conclusions:
- Haptocorrin (HC) is not significantly stored in healthy or steatotic liver cells.
- Hepatic carcinogenesis, particularly HCC, is associated with increased HC expression within tumor cells and surrounding hepatocytes.
- Findings support the hypothesis that elevated serum HC in HCC results from increased hepatic synthesis and reduced hepatic uptake.